Testicular Carcinoma Worksheet 4.0.1.0

Specimen and Tumor Data

Case Number Case Number:

Laterality Right
Left

Tumor Focality Unifocal
Multifocal
Tumor size (cm): cm.
(Note: for multifocal tumors, give additional
maximum dimensions in comment)

Tumor Type ITGCN type:
Seminoma
Seminoma with synciotrophbloast cells
Seminoma with associated scar
Spermatocytic tumor (née spermatocytic seminoma)
Embryonal carcinoma
Yolk sac tumor
Choriocarcinoma
Mixed germ cell tumor

TUMOR TYPE	PERCENTAGE
Seminoma	%
Embryonal carcinoma	%
Yolk sac tumor	%
Choriocarcinoma	%
Other:	%

Non-choriocarcinomatous GCT type:
Scar diagnostic of regressed germ cell tumor
Scar suspicious of regressed germ cell tumor
Mixed germ cell-sex cord stromal tumor, gonadoblastoma
Sex Cord-Stromal Tumor type:

Tumor Extension Primary tumor cannot be assessed
No evidence of primary tumor
Germ cell neoplasia in situ only
Tumor limited to testicular parenchyma
Tumor invades rete testis
Tumor invades hilar soft tissue
Tumor invades epididymis
Tumor invades spermatic cord

Tumor invades the tunica albuginea
Tumor perforates tunica vaginalis
Tumor invades scrotum

Lymphovascular Invasion Not identified
Present

Staging

Margins Spermatic cord margin:
Clear
Microscopically positive for tumor
Grossly positive for tumor

Scrotal margin:
N/A
Clear
Microscopically positive for tumor
Grossly positive for tumor

Lymph Node Status

No lymph nodes sampled
No tumor identified in lymph nodes.
Metastatic tumor identified in of nodes.

Size of Largest Lymph Node (or Nodal Mass) Involved: cm.
Size of Largest metastatic deposit (optional): cm.
Histologic subtype of tumor in involved lymph nodes:

Extranodal extension:
N/A
Not identified
Present

Metastasis Status No tissue submitted for metastatic examination
Tissue submitted and NEGATIVE for metastatic disease
Tissue submitted and POSITIVE for metastatic disease

Metastasis to non-regional lymph node(s)
Site:
Metastatic to lung
Metastatic to other visceral site(s)
Site:

Serum Markers

Marker	Normal Cutoff	Patient Values
LDH
hCG
AFP

Final Report

	Modifiers Multiple Primary Tumors (m) Recurrent Tumor (r) Post-treatment Staging (y)	Other Findings Germ cell neoplasia in situ (GCNIS) Leydig cell hyperplasia (may be associated with hCG elevation Microlith Sertoli cell nodule (Pick’s adenoma, usually associated with undescended testes) Atrophy
Comments Original H&Es and deeper sections are examined. Case reviewed in departmental conference. Pankeratin immunostain used in evaluation. Vimentin immunostain used in evaluation. AFP immunostain used in evaluation. Ki-1 immunostain used in evaluation. PlAP immunostain used in evaluation. hCG immunostain used in evaluation.		Free-text Comments